Onsdag 28 Oktober | 18:12:18 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Paxman Q3’22 - Strong momentum

2022-11-21 07:19:00

Redeye is once again impressed by the sales progression. The signs that the scalp-cooling market transformation is underway are underscored company and give us continued confidence in the long-term growth case we see in Paxman. With some positive estimate adjustments due to the beat in the quarter and a negative one regarding the risk-free interest rate, we have adjusted our fair value range slightly downwards. our fair value range is now SEK 43 to SEK 132 per share with a Base case value of SEK 89 per share.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.